Cargando…
Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma
Although breakthroughs have been made in the treatment of non-small cell lung cancer, there are only a few choices for advanced-stage or recurrent lung squamous cell carcinoma (LUSC) patients. In our study, we identified 7 major cell types in thedepicted the immunolandscape of LUSC microenvironment...
Autores principales: | Hao, Bo, Zhang, Ziyao, Lu, Zilong, Xiong, Juan, Fan, Tao, Song, Congkuan, He, Ruyuan, Zhang, Lin, Pan, Shize, Li, Donghang, Meng, Heng, Lin, Weichen, Luo, Bin, Yang, Jinfeng, Li, Ning, Geng, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586982/ https://www.ncbi.nlm.nih.gov/pubmed/36270103 http://dx.doi.org/10.1016/j.tranon.2022.101568 |
Ejemplares similares
-
Systematic analysis of histone acetylation regulators across human cancers
por: Song, Congkuan, et al.
Publicado: (2023) -
The prognostic value of tumor-stromal ratio combined with TNM staging system in esophagus squamous cell carcinoma
por: He, Ruyuan, et al.
Publicado: (2021) -
Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery
por: Song, Congkuan, et al.
Publicado: (2022) -
Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance
por: Pan, Shize, et al.
Publicado: (2022) -
Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
por: Pan, Shize, et al.
Publicado: (2022)